Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 4 for AbbVie Inc..
AbbVie Inc.: 0 warning letters, 4 recalls, 0 approval records, 0 Form 483s.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Side by side
AbbVie Inc. — Warning letters0
Philips North America — Warning letters0
AbbVie Inc. — Recalls4
Philips North America — Recalls355
AbbVie Inc. — Approval records0
Philips North America — Approval records0
AbbVie Inc. — Form 483s0
Philips North America — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"AbbVie Inc. vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/abbvie-inc-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗